The Basaglar insulin is indicated for the treatment of diabetes mellitus type 2 and diabetes mellitus type 1 in people who require long-term insulin for the control of high levels of blood sugar.
This is a biosimilar medicine, as it is the cheapest copy, but with the same effectiveness and safety as Lantus, which is the reference medicine for this treatment. This insulin is manufactured by the companies Eli Lilly and Boehringer Ingelheim , together, and was recently approved by ANVISA for commercialization in Brazil.
Basaglar insulin can be purchased in pharmacies, for a price of about 170 reais, upon presentation of a prescription.
Basaglar insulin is indicated for the treatment of Diabetes mellitus type 2 and Diabetes mellitus type 1, in adults or children older than 2 years, who need the action of long-acting insulin to control excess sugar in blood and must be indicated by the doctor.
This medicine works by lowering blood glucose levels in the bloodstream and allowing glucose to be used by cells in the body throughout the day and is usually used with other types of fast-acting insulin or with oral antidiabetics. Understand what are the main medicines used to treat diabetes, and when insulin is indicated .
Basaglar insulin is used through injections applied to the subcutaneous layer of skin in the abdomen, thigh or arm. Applications are made once a day, always at the same time, as directed by the doctor.
Some of the most common side effects that can be caused by the use of Basaglar insulin are hypoglycemia, allergic reactions, reactions at the injection site, abnormal distribution of fat in the body, generalized itching, skin reactions, swelling and weight gain.
Basaglar insulin is contraindicated in people allergic to insulin glargine or any of the components of the medicine’s formula.